polysaccharides, bacterial

Preferred Label : polysaccharides, bacterial;

MeSH definition : Polysaccharides found in bacteria and in capsules thereof.;

MeSH synonym : bacterial polysaccharides;

MeSH annotation : general or unspecified; prefer specifics; coordinate with specific bacterium specific polysaccahride if pertinent;

Is substance : O;

Details

Origin ID

D011135;

UMLS CUI

C0032595;

ATC code(s)
- meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein [ATC Code]
- meningococcus A,C, bivalent purified polysaccharides antigen [ATC Code]
- meningococcus a, purified polysaccharides antigen [ATC Code]
- other meningococcal monovalent purified polysaccharides antigen [ATC Code]
- other meningococcal polyvalent purified polysaccharides antigen [ATC Code]
- pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated [ATC Code]
- pneumococcus, purified polysaccharides antigen [ATC Code]
- pneumococcus, purified polysaccharides antigen conjugated [ATC Code]
- typhoid, purified polysaccharide antigen [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Bacterial Glycan [NCIt concept]
Indexing information
- 3-azidopropyl (5-acetamido-3,5-dideoxy-2-nonulopyranosylonic acid)-2-3-galactopyranosyl-1-4-rhamnopyranosyl-1-4-glucopyranosyl-1-4-(5-acetamido-3,5-nonulopyranosylonic acid-2-3)galactopyranoside [MeSH Supplementary Concept]
- 5-acetamido-3,5,7,9-tetradeoxy-7-(3-hydroxybutyramido)nonulosonic acid [MeSH Supplementary Concept]
- 6-deoxyaltritol [MeSH Supplementary Concept]
- alpha-1,3-dextran [MeSH Supplementary Concept]
- arabinogalactan [MeSH Supplementary Concept]
- arabinogalactan mycolate [MeSH Supplementary Concept]
- arabinomannan [MeSH Supplementary Concept]
- colanic acid [MeSH Supplementary Concept]
- curdlan [MeSH Supplementary Concept]
- galactan F [MeSH Supplementary Concept]
- levan [MeSH Supplementary Concept]
- mucoid exopolysaccharide (P aeruginosa) [MeSH Supplementary Concept]
- poly(galactosylglycerol phosphate) [MeSH Supplementary Concept]
- polyglycerolphosphate [MeSH Supplementary Concept]
- polyribitol phosphate [MeSH Supplementary Concept]
- polysaccharide S3 [MeSH Supplementary Concept]
- polysaccharide S8 [MeSH Supplementary Concept]
- polysialic acid [MeSH Supplementary Concept]
- porphyran [MeSH Supplementary Concept]
- pseudomonas aeruginosa O polysaccharide-toxin A conjugate vaccine [MeSH Supplementary Concept]
- pyrecol [MeSH Supplementary Concept]
- streptococcus mutans polysaccharide-saliva receptor protein conjugate [MeSH Supplementary Concept]
- teichuronic acid [MeSH Supplementary Concept]
- teichuronopeptide [MeSH Supplementary Concept]
Record concept(s)
- polysaccharides, bacterial [MeSH concept]
Related MeSH Supplementary Concept(s)
- (chitosan-g-glycidyl methacrylate)-xanthan [MeSH Supplementary Concept]
- 2,3,4-triacetamido-2,3,4-trideoxy-L-arabinose [MeSH Supplementary Concept]
- 4-epilegionaminic acid homopolymer [MeSH Supplementary Concept]
- 4-trifluoroacetamidophenyl-1-O-glucopyranosylribitol-1'-phosphate [MeSH Supplementary Concept]
- ALG polysaccharide, pseudomonas aeruginosa [MeSH Supplementary Concept]
- Ch HF-PS [MeSH Supplementary Concept]
- DMG polysaccharide [MeSH Supplementary Concept]
- EPS11 compound [MeSH Supplementary Concept]
- EPSI polysaccharide [MeSH Supplementary Concept]
- HE 800, vibrio diabolicus [MeSH Supplementary Concept]
- K polysaccharide, rhizobium meliloti [MeSH Supplementary Concept]
- K101 capsular antigen, E coli [MeSH Supplementary Concept]
- K19 capsular polysaccharide, Acinetobacter baumannii [MeSH Supplementary Concept]
- K27 polysaccharide, E. coli [MeSH Supplementary Concept]
- K6-antigen [MeSH Supplementary Concept]
- Kocuran [MeSH Supplementary Concept]
- Mencevax AC [MeSH Supplementary Concept]
- Midi-GAGR [MeSH Supplementary Concept]
- N-propyl group B meningococcal polysaccharide [MeSH Supplementary Concept]
- O-methylglucose polysaccharide [MeSH Supplementary Concept]
- O-polysaccharide, proteus mirabilis O40 [MeSH Supplementary Concept]
- O-polysaccharide, providencia stuartii O43 [MeSH Supplementary Concept]
- O-polysaccharide, providencia stuartii O44 [MeSH Supplementary Concept]
- O-specific polysaccharide, hafnia alvei [MeSH Supplementary Concept]
- O-specific polysaccharide, salmonella cerro [MeSH Supplementary Concept]
- PolyGlycoplex [MeSH Supplementary Concept]
- RMDP17 [MeSH Supplementary Concept]
- S 657 [MeSH Supplementary Concept]
- Ty21a typhoid vaccine [MeSH Supplementary Concept]
- Vi polysaccharide vaccine, typhoid [MeSH Supplementary Concept]
- acetan [MeSH Supplementary Concept]
- alasan protein, acinetobacter radioresistens [MeSH Supplementary Concept]
- amylovoran [MeSH Supplementary Concept]
- antigen III cell wall polysaccharide, trichosporon domesticum [MeSH Supplementary Concept]
- antistreptopolysaccharide [MeSH Supplementary Concept]
- bacterial adhesins, polysaccharide [MeSH Supplementary Concept]
- beijeran [MeSH Supplementary Concept]
- biodispersan [MeSH Supplementary Concept]
- capsular polysaccharide 10A [MeSH Supplementary Concept]
- capsular polysaccharide K1 [MeSH Supplementary Concept]
- capsular polysaccharide S21 [MeSH Supplementary Concept]
- capsular polysaccharide, Salmonella [MeSH Supplementary Concept]
- carboxymethyl gellan gum [MeSH Supplementary Concept]
- cell wall polysaccharide, actinoplanes [MeSH Supplementary Concept]
- cell wall polysaccharide, streptococcus [MeSH Supplementary Concept]
- cepacian [MeSH Supplementary Concept]
- chitoxan [MeSH Supplementary Concept]
- chlamydial exoglycolipid antigen [MeSH Supplementary Concept]
- compact-colony-forming active substance [MeSH Supplementary Concept]
- deacylated beijeran [MeSH Supplementary Concept]
- deacylated phosphatidylinositol manno-oligosaccharide-8, gordonia sputi [MeSH Supplementary Concept]
- ebosin [MeSH Supplementary Concept]
- emulsan [MeSH Supplementary Concept]
- exopolysaccharide B39 [MeSH Supplementary Concept]
- exopolysaccharide V2-7, halomonas [MeSH Supplementary Concept]
- exopolysaccharide biopolymer, bacillus coagulans [MeSH Supplementary Concept]
- exopolysaccharide, bacillus [MeSH Supplementary Concept]
- exopolysaccharide, enterobacter amnigenus [MeSH Supplementary Concept]
- exopolysaccharide, pseudomonas [MeSH Supplementary Concept]
- exopolysaccharide, streptococcus [MeSH Supplementary Concept]
- extracellular polysaccharide 6 [MeSH Supplementary Concept]
- fucogel [MeSH Supplementary Concept]
- galactoglucan [MeSH Supplementary Concept]
- gellan gum [MeSH Supplementary Concept]
- glucose-N-acetylaminomannuronic acid polymer [MeSH Supplementary Concept]
- gordonan [MeSH Supplementary Concept]
- haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine [MeSH Supplementary Concept]
- immulina [MeSH Supplementary Concept]
- lipopolysaccharide O-chain, naxibacter alkalitolerans [MeSH Supplementary Concept]
- mauran [MeSH Supplementary Concept]
- meningococcal group A polysaccharide [MeSH Supplementary Concept]
- meningococcal group C polysaccharide [MeSH Supplementary Concept]
- meningococcal group C polysaccharide-tetanus toxoid conjugate [MeSH Supplementary Concept]
- methanochondroitin [MeSH Supplementary Concept]
- microellobosporia griesea polyalcoholized mannoglucan [MeSH Supplementary Concept]
- mucoidan, rhodococcus erythropolis [MeSH Supplementary Concept]
- neuraminin [MeSH Supplementary Concept]
- piromen [MeSH Supplementary Concept]
- pneumococcal polysaccharide 14 - CRM 197 [MeSH Supplementary Concept]
- pneumococcal polysaccharide type 1 [MeSH Supplementary Concept]
- pneumococcal polysaccharide type 17A [MeSH Supplementary Concept]
- pneumococcal polysaccharide type 17F [MeSH Supplementary Concept]
- pneumococcal polysaccharide type 29 [MeSH Supplementary Concept]
- pneumococcal polysaccharide type 6 [MeSH Supplementary Concept]
- pneumococcal polysaccharide type 9V [MeSH Supplementary Concept]
- pneumococcal polysaccharide, type 37 [MeSH Supplementary Concept]
- pneumococcal polysaccharide, type 7 [MeSH Supplementary Concept]
- pneumococcal polysaccharide, type 8 [MeSH Supplementary Concept]
- pneumococcal polysaccharide, type II [MeSH Supplementary Concept]
- pneumococcal polysaccharide, type III [MeSH Supplementary Concept]
- pneumonococcal polysaccharide, type 4 [MeSH Supplementary Concept]
- poly((4,6-O-(1-carboxyethylidene))-N-acetylmannosaminyl-1-4-N-acetylglucosaminyl-1-3-) [MeSH Supplementary Concept]
- poly(N-acetylglucosamine 1-phosphate) [MeSH Supplementary Concept]
- poly-N-succinyl beta-1-6-glucosamine [MeSH Supplementary Concept]
- polyguluronic acid [MeSH Supplementary Concept]
- polyribose phosphate [MeSH Supplementary Concept]
- polysaccharide C-substance (Streptococcus) [MeSH Supplementary Concept]
- polysaccharide II, burkholderia [MeSH Supplementary Concept]
- polysaccharide II, clostridium difficile [MeSH Supplementary Concept]
- polysaccharide S-156 [MeSH Supplementary Concept]
- polysaccharide S-84 [MeSH Supplementary Concept]
- polysaccharide intercellular adhesin [MeSH Supplementary Concept]
- proteisane [MeSH Supplementary Concept]
- pyrifolan [MeSH Supplementary Concept]
- rhamsan [MeSH Supplementary Concept]
- salmozan [MeSH Supplementary Concept]
- simusan [MeSH Supplementary Concept]
- soluble polysaccharide, trichosporon domesticum [MeSH Supplementary Concept]
- sphingan [MeSH Supplementary Concept]
- stewartan [MeSH Supplementary Concept]
- streptococcal group A cell wall carbohydrate [MeSH Supplementary Concept]
- streptococcal polysaccharide group A [MeSH Supplementary Concept]
- streptococcal polysaccharide ia group B [MeSH Supplementary Concept]
- streptococcal polysaccharide ib group B [MeSH Supplementary Concept]
- streptococcal polysaccharide type II-tetanus toxoid conjugate vaccine [MeSH Supplementary Concept]
- streptococcal polysaccharide type III group B [MeSH Supplementary Concept]
- streptococcal polysaccharide-tetanus toxoid conjugate vaccine [MeSH Supplementary Concept]
- streptococcus pneumoniae type 12F polysaccharide [MeSH Supplementary Concept]
- succinoglucan exopolysaccharide [MeSH Supplementary Concept]
- succinoglycan [MeSH Supplementary Concept]
- tecogalan [MeSH Supplementary Concept]
- varianose [MeSH Supplementary Concept]
- viilian [MeSH Supplementary Concept]
- welan [MeSH Supplementary Concept]
- xanthan gum [MeSH Supplementary Concept]
- xylinan [MeSH Supplementary Concept]
- zanflo [MeSH Supplementary Concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients